Image-Guided Radiation Therapy Market By Product (4D RT, LINAC, MRI-guided Radiotherapy, Portal Imaging, CT Scanning), By Procedure (IMRT (intensity modulation radiation therapy), Stereotactic Therapy, Particle Therapy, Others) By End User (Hospitals, Ind

Image-Guided Radiation Therapy Market By Product (4D RT, LINAC, MRI-guided Radiotherapy, Portal Imaging, CT Scanning), By Procedure (IMRT (intensity modulation radiation therapy), Stereotactic Therapy, Particle Therapy, Others) By End User (Hospitals, Independent Radiotherapy Centers, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033

Image-guided Radiation Therapy Market

The image-guided radiation therapy market was valued at $1.9 billion in 2023 and is projected to reach $3.3 billion by 2033, growing at a CAGR of 5.7% from 2024 to 2033.

Image-guided radiation therapy is a frequent imaging process used in the treatment of cancer. The therapy involves several imaging techniques such as MRI, PET, and CT scans, which allow for precise targeting of radiation for killing the cancer cells. The precise targeting is performed using the high-quality images generated by imaging technologies. This approach elevates the accuracy of treatment, improves therapy outcomes, and reduces radiation-related complications, making image-guided radiation therapy a necessary procedure in modern oncology practice.

Increase in prevalence of diverse forms of cancers and rise in demand for targeted cancer treatment are the major drivers of the image-guided radiation therapy market. In addition, the deployment of real-time imaging during ongoing treatment sessions has boosted the efficacy of treatment, thereby boosting the demand for image-guided radiation therapy. Surface-guided radiation therapy has recently witnessed widespread adoption in several oncology facilities due to its cutting-edge attributes such as intra-fraction motion monitoring and respiratory gating.

However, the cost associated with procuring instruments related to image-guided radiation therapy, along with the high costs of treatment for the patients, is a major restraint for the market. On the contrary, enhancements in technology are diversifying the prospects of the therapy and refining the healing process. Assimilation of AI and ML is enabling the delivery of personalized cancer treatment according to the vitals and requirements of the patient. For instance, in the case of a patient suffering from glioblastoma, an AI-based dose optimization software was used to tailor the radiation therapy. This included the delivery of optimal dose of radiation, resulting in maximum tumor control while guarding the pivotal parts of the brain such as brainstem and optic nerves.

Segment Review

The image-guided radiation therapy market is segmented into product, procedure, end user, and region. On the basis of product, the market is divided into 4D RT, LINAC, MRI-guided radiotherapy, portal imaging, and CT scanning. By procedure, it is classified into IMRT (intensity modulation radiation therapy), stereotactic therapy, particle therapy, and others. Depending on end user, it is categorized into hospitals, independent radiotherapy centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of product, the LINAC segment dominates the market.

By procedure, the IMRT (intensity modulation radiation therapy) segment is the leader in the market.

Region wise, North America is projected to be the highest revenue generator by 2033.

Competition Analysis

The major players operating in the global image-guided radiation therapy market include Varian Medical Systems, Inc., Elekta AB, Accuray Incorporated, ViewRay, Inc., Siemens Healthineers AG, Hitachi, Ltd, Brainlab AG, MEVION MEDICAL SYSTEMS, INC., C-Rad AB, Sumitomo Heavy Industries, Ltd., and Philips Healthcare. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Key Market Segments

By Product

4D RT
LINAC
MRI-guided Radiotherapy
Portal Imaging
CT Scanning

By Procedure

IMRT (intensity modulation radiation therapy)
Stereotactic Therapy
Particle Therapy
Others

By End User

Hospitals
Independent Radiotherapy Centers
Others

By Region

North America
U.S.
Canada
Mexico
Europe
France
Germany
Italy
Spain
UK
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Saudi Arabia
Rest of LAMEA
Key Market Players
Varian Medical Systems, Inc.
Elekta AB, Accuray Incorporated
ViewRay, Inc.
Siemens Healthineers AG
Hitachi, Ltd
Brainlab AG
MEVION MEDICAL SYSTEMS, INC.
C-Rad AB
Sumitomo Heavy Industries, Ltd.
Philips Healthcare

Please Note: It will take 7-10 business days to complete the report upon order confirmation.